Canadian Life Insurance Medical Officers Association
Association Canadienne des Directeurs Médicaux en Assurance-Vie

CLIMOA heartbeat

CLIMOA's Past Programs

 

2000 Summary of the Presentations

Breast Cancer:
Genetic Testing and Insurance
ANGELA M.W. CHEUNG, MD, FRCP(C)
Associate Director, Women’s Health Program,
University Health Network

Assistant Professor, Faculty of Medicine,
University of Toronto Toronto, Ontario

Pitfalls in the Reading of Echocardiograms:
An insurance medicine perspective
ZION S. SASSON, MD, FRCP(C)
Medical Director, Gerling Global Life Reinsurance

Medical Consultant, Optimum Reinsurance
Staff, Cardiology Division, Mount Sinai Hospital

Assistant Professor, Faculty of Medicine,
University of Toronto Toronto, Ontario

Prosthetic heart valves:
New developments and improved mortality
J. GASTON DUMESNIL, MD, FRCP(C)

Staff, Cardiology Division, Laval Hospital
Professor, Faculty of Medicine,
Laval University

Sainte-Foy, Quebec

Liver Enzymes and alcohol markers:
Fact and fantasy
SUZANNE MORIN, MD, FRCP(C)
Medical Consultant, Standard Life

Staff, Department of Medicine,
Montreal General Hospital
Assistant Professor, Faculty of Medicine,
McGill University

Montreal, Quebec

Be it resolved that the underwriting manual should be an expression of mortality rather than a marketing tool HOWARD L. MINUK, MD, FRCP(C)?

Chief Medical Director, Swiss Re Life &
Health America, Inc.
Medical Director, Prudential of America Life
Insurance (Canada)
Medical Director, Norwich Union Life Insurance
(Canada)

Toronto, Ontario

JOHN KRINIK
Publisher, Underwriter ALERT
Executive Editor, On The Risk

Binghamton, New York

Lymphoma: Prognosis in the new millennium PIERRE F. LEBLOND, MDSenior Staff, Hematology Division, Departments of Medicine and Laboratory Medicine,
University Hospital of Quebec
Professor, Department of Medicine,
Laval University

Sainte-Foy, Quebec

RMD: Insuring the uninsurable cancers TIMOTHY W. MEAGHER, MD, FRCP(C)Chief Medical Officer,
Standard Life Insurance Company
Assistant Medical Director,
Munich Reinsurance Company

Senior Physician, Department of Medicine,
Montreal General Hospital
Associate Physician-in-Chief,
Department of Medicine,
McGill University Health Sciences Centre
Associate Professor, Faculty of Medicine,
McGill University

Montreal, Quebec

The use of pulmonary function tests in insurance medicine ROGER T. MICHAEL, MD, FCCP, FRCP(C)

Medical Director,
The Maritime Life Assurance Company

Medical Director, Adult Cystic Fibrosis Clinic,
Queen Elizabeth II Health Sciences Centre
Assistant Professor, Department of Medicine,
Dalhousie University

Halifax, Nova Scotia

Renal transplantation:
Changes in mortality
ISABELLE HOUDE, MD

Staff, Division of Nephrology,
University Hospital of Quebec,

Quebec, Quebec

International underwriting:
Similarities and differences
PHILLIP S. SMALLEY, MD, FRCP(C)

Vice-President and Managing Director,
RGA International Ltd.
Managing Director, Longer Life Foundation

Toronto, Ontario

Senior moment or early dementia?
Distinguishing the normal from the abnormal
REMI BOUCHARD, MD, FRCP(C)

Associate Professor, Neurology Divison,
Laval University
Vice-Dean Postgraduate Medical Studies,
McGill University

Quebec, Quebec

New guidelines in the treatment of hypertension:
Impact on mortality

E. CARL ABBOTT, MD, FACP, FRCP(C)

Consultant, The Maritime Life Assurance Company
Active Staff, Internal Medicine Division,
Queen Elizabeth II
Health Sciences Centre
Associate Professor, Faculty of Medicine,
Dalhousie University

Halifax, Nova Scotia

Be it resolved that provincial formularies are a unseful reference for private health insurance drug plans

MICHAEL MORIARITY
Publisher and Editorial Director,
Employee Health and Productivity

Toronto, Ontario

Kevin Skilton,
Director of Health Policy, Merck Frosst
Canada & Co

An approach to the valuation of pain syndromes in disablity claims PAUL B. TEPPERMAN, MD

Vice-President,
King's Health Centre

Disability management comes of age DAVID BROWN, MD

Director, Health Centre,
CIBC and CIBC Insurance

Toronto, Ontario

An effective management strategy in dealing with mental and nervous disorders MICHEL BROCHU, MD, FRCP(C)

Consulting Psychiatrist,
Assurance-Vie Desjardins-Laurentienne
Active Staff, Psychiatry Division,
Hotel-Dieu de Levis

Levis, Quebec

Mental Health:
The Ultimate productivity weapon

BILL WILKERSON

President,
Canadian Business and Economic Roundtable on Mental Health

Toronto, Ontario

A course in insurance medicine:
University of Montreal
FRANÇOIS SESTIER, MD, PhD

Medical Director,Blue Cross Quebec
Associate Professor, Faculty of Medicine,
University of Montreal

Montreal, Quebec

Heart outcome prevention evaluation (HOPE)
study motrality implications

J.L. GUY TREMBLAY, MD, FRCP(C)

Physician,
Optimum-Re MFQ Vie Corporation d’Assurance
Affiliated Staff, Cardiology Division, Laval University

Quebec, Quebec

Micro-hope study PAUL RENÉ DE COTRET, MD, FRCP(C)

Staff, Department of Medicine,
University Hospital of Quebec,

Sainte-Foy, Quebec

New risk faxtors in coronary artery disease:
Central obesity and hyperinsulinism; Do they influence morbidity and mortality?
JEAN-PIERRE DESPRÉS, PhD

Scientific Director, Quebec Heart Institute
Scientific Director, Lipid Research Centre,
Laval Hospital
Professor, Faculty of Medicine,
Laval University

Sainte-Foy, Quebec

Be it resolved that given our current knowledge regarding diabetes mellitus that insurance companies are liberal in their underwriting of this condition THOMAS G. ELLIOTT, MD

Medical Consultant,
Seabord Insurance Company

Staff, Department of Medicine,
Vancouver Hospital and Health Sciences Centre Assistant Professor, Faculty of Medicine,
University of British Columbia

CLAUDE R. CATELLIER, MD

Medical Consultant,
Industrial-Alliance Life Insurance Company (Sillery)

Associate Staff, Department of Medicine,
University Hospital of Quebec
Professor, Faculty of Medicine, Laval University

Sainte-Foy, Quebec